The synergistic effects of a triple conjugate targeting system, consisting of CDs conjugated to transferrin and the chemotherapeutic compounds epiburicin and TMZ, on pediatric and adult glioma cells, have also been investigated in vitro [39]. The gene discussed is TF; the disease is glioma.